- Home
- SA vs OPK Comparison
SA vs OPK Comparison
Compare SA & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SA
- OPK
- Stock Information
- Founded
- SA 1979
- OPK 2007
- Country
- SA Canada
- OPK United States
- Employees
- SA N/A
- OPK N/A
- Industry
- SA Precious Metals
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- SA Basic Materials
- OPK Health Care
- Exchange
- SA Nasdaq
- OPK Nasdaq
- Market Cap
- SA 1.0B
- OPK 1.0B
- IPO Year
- SA N/A
- OPK 1995
- Fundamental
- Price
- SA $12.58
- OPK $1.58
- Analyst Decision
- SA
- OPK Strong Buy
- Analyst Count
- SA 0
- OPK 3
- Target Price
- SA N/A
- OPK $2.75
- AVG Volume (30 Days)
- SA 577.1K
- OPK 2.9M
- Earning Date
- SA 03-28-2025
- OPK 02-25-2025
- Dividend Yield
- SA N/A
- OPK N/A
- EPS Growth
- SA N/A
- OPK N/A
- EPS
- SA N/A
- OPK N/A
- Revenue
- SA N/A
- OPK $711,408,000.00
- Revenue This Year
- SA N/A
- OPK N/A
- Revenue Next Year
- SA N/A
- OPK $0.00
- P/E Ratio
- SA N/A
- OPK N/A
- Revenue Growth
- SA N/A
- OPK N/A
- 52 Week Low
- SA $9.31
- OPK $0.86
- 52 Week High
- SA $20.55
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- SA 53.83
- OPK 55.91
- Support Level
- SA $11.57
- OPK $1.47
- Resistance Level
- SA $12.78
- OPK $1.51
- Average True Range (ATR)
- SA 0.43
- OPK 0.04
- MACD
- SA 0.14
- OPK 0.01
- Stochastic Oscillator
- SA 79.34
- OPK 94.44
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.